BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 2462601)

  • 21. Transfer of immunity to cryptococcosis by T-enriched splenic lymphocytes from Cryptococcus neoformans-sensitized mice.
    Lim TS; Murphy JW
    Infect Immun; 1980 Oct; 30(1):5-11. PubMed ID: 7002791
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Functional testing and chemical composition of cryptococcal extracts.
    Hall NK; Maluf KC; Blackstock R
    Sabouraudia; 1984; 22(5):439-42. PubMed ID: 6390739
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of cyclosporine in experimental cryptococcal meningitis.
    Perfect JR; Durack DT
    Infect Immun; 1985 Oct; 50(1):22-6. PubMed ID: 3899932
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Suppression of responses to cryptococcal antigen in murine cryptococcosis.
    Robinson BE; Hall NK; Bulmer GS; Blackstock R
    Mycopathologia; 1982 Dec; 80(3):157-63. PubMed ID: 6219291
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of immunization with Cryptococcus neoformans cells or cryptococcal culture filtrate antigen on direct anticryptococcal activities of murine T lymphocytes.
    Muth SM; Murphy JW
    Infect Immun; 1995 May; 63(5):1645-51. PubMed ID: 7729868
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cryptococcal latex antigen test positive in patient with Trichosporon beigelii infection.
    Campbell CK; Payne AL; Teall AJ; Brownell A; Mackenzie DW
    Lancet; 1985 Jul; 2(8445):43-4. PubMed ID: 2861489
    [No Abstract]   [Full Text] [Related]  

  • 27. A Call to Arms: Quest for a Cryptococcal Vaccine.
    Caballero Van Dyke MC; Wormley FL
    Trends Microbiol; 2018 May; 26(5):436-446. PubMed ID: 29103990
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Methodology for Anti-Cryptococcal Vaccine Development.
    Chaturvedi AK; Wormley FL
    Methods Mol Biol; 2017; 1625():129-140. PubMed ID: 28584988
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cryptococcal interstitial pneumonia: value of antigen determination.
    Fisher BD; Armstrong D
    N Engl J Med; 1977 Dec; 297(26):1440-1. PubMed ID: 337142
    [No Abstract]   [Full Text] [Related]  

  • 30. Role of the latex agglutination test for cryptococcal antigen in diagnosing disseminated infections with Trichosporon beigelii.
    McManus EJ; Bozdech MJ; Jones JM
    J Infect Dis; 1985 Jun; 151(6):1167-9. PubMed ID: 3889173
    [No Abstract]   [Full Text] [Related]  

  • 31. Optimal T cell responses to Cryptococcus neoformans mannoprotein are dependent on recognition of conjugated carbohydrates by mannose receptors.
    Mansour MK; Schlesinger LS; Levitz SM
    J Immunol; 2002 Mar; 168(6):2872-9. PubMed ID: 11884457
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Monoclonal antibody to fungal glucosylceramide protects mice against lethal Cryptococcus neoformans infection.
    Rodrigues ML; Shi L; Barreto-Bergter E; Nimrichter L; Farias SE; Rodrigues EG; Travassos LR; Nosanchuk JD
    Clin Vaccine Immunol; 2007 Oct; 14(10):1372-6. PubMed ID: 17715331
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CD8 cells play a critical role in delayed type hypersensitivity to intact Cryptococcus neoformans.
    Mody CH; Paine R; Jackson C; Chen GH; Toews GB
    J Immunol; 1994 Apr; 152(8):3970-9. PubMed ID: 8144964
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Latex-cryptococcal antigen test.
    Kaufman L; Blumer S
    Am J Clin Pathol; 1973 Aug; 60(2):285-6. PubMed ID: 4578471
    [No Abstract]   [Full Text] [Related]  

  • 35. Protective cell-mediated immunity against Cryptococcus neoformans.
    Murphy JW
    Res Immunol; 1998; 149(4-5):373-86; discussion 519-22. PubMed ID: 9720955
    [No Abstract]   [Full Text] [Related]  

  • 36. Detection of cryptococcal polysaccharide using counterimmunoelectrophoresis.
    Maccani JE
    Am J Clin Pathol; 1977 Jul; 68(1):39-44. PubMed ID: 326030
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Depletion of murine CD8+ T cells in vivo decreases pulmonary clearance of a moderately virulent strain of Cryptococcus neoformans.
    Mody CH; Chen GH; Jackson C; Curtis JL; Toews GB
    J Lab Clin Med; 1993 Jun; 121(6):765-73. PubMed ID: 7685044
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The role of the classical and alternate complement pathways in host defenses against Cryptococcus neoformans infection.
    Diamond RD; May JE; Kane MA; Frank MM; Bennett JE
    J Immunol; 1974 Jun; 112(6):2260-70. PubMed ID: 4596700
    [No Abstract]   [Full Text] [Related]  

  • 39. Cryptococcal capsular polysaccharide-induced modulation of murine immune responses.
    Breen JF; Lee IC; Vogel FR; Friedman H
    Infect Immun; 1982 Apr; 36(1):47-51. PubMed ID: 6210638
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Detection of circulating capsular polysaccharide antigen from Cryptococcus neoformans.
    Swinne D; De Vroey C
    J Clin Microbiol; 1992 Sep; 30(9):2521. PubMed ID: 1401033
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.